Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/20739
Type
ArticleCopyright
Open access
Collections
- IOC - Artigos de Periódicos [12512]
Metadata
Show full item record
STRUCTURAL MODELLING AND COMPARATIVE ANALYSIS OF HOMOLOGOUS, ANALOGOUS AND SPECIFIC PROTEINS FROM TRYPANOSOMA CRUZI VERSUS HOMO SAPIENS: PUTATIVE DRUG TARGETS FOR CHAGAS’ DISEASE TREATMENT
Author
Affilliation
Laboratório Nacional de Computação Científica, LNCC/MCT. Grupo de Modelagem Molecular de Sistemas Biológicos. Petrópolis, RJ, Brasil
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Genômica Funcional e Bioinformática. Rio de Janeiro, RJ. Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Genômica Funcional e Bioinformática. Rio de Janeiro, RJ. Brasil / Parasite Genomics. Wellcome Trust Sanger Institute. Wellcome Trust Genome Campus. Cambridge, UK.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Biologia Computacional e Sistemas. Rio de Janeiro, RJ. Brasil.
Laboratório Nacional de Computação Científica, LNCC/MCT. Grupo de Modelagem Molecular de Sistemas Biológicos. Petrópolis, RJ, Brasil
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Genômica Funcional e Bioinformática. Rio de Janeiro, RJ. Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Genômica Funcional e Bioinformática. Rio de Janeiro, RJ. Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Genômica Funcional e Bioinformática. Rio de Janeiro, RJ. Brasil / Parasite Genomics. Wellcome Trust Sanger Institute. Wellcome Trust Genome Campus. Cambridge, UK.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Biologia Computacional e Sistemas. Rio de Janeiro, RJ. Brasil.
Laboratório Nacional de Computação Científica, LNCC/MCT. Grupo de Modelagem Molecular de Sistemas Biológicos. Petrópolis, RJ, Brasil
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Genômica Funcional e Bioinformática. Rio de Janeiro, RJ. Brasil.
Abstract
Background: Trypanosoma cruzi is the etiological agent of Chagas’ disease, an endemic infection that causes
thousands of deaths every year in Latin America. Therapeutic options remain inefficient, demanding the search for
new drugs and/or new molecular targets. Such efforts can focus on proteins that are specific to the parasite, but
analogous enzymes and enzymes with a three-dimensional (3D) structure sufficiently different from the
corresponding host proteins may represent equally interesting targets. In order to find these targets we used the
workflows MHOLline and AnEnΠ obtaining 3D models from homologous, analogous and specific proteins of
Trypanosoma cruzi versus Homo sapiens.
Results: We applied genome wide comparative modelling techniques to obtain 3D models for 3,286 predicted
proteins of T. cruzi. In combination with comparative genome analysis to Homo sapiens, we were able to identify a
subset of 397 enzyme sequences, of which 356 are homologous, 3 analogous and 38 specific to the parasite.
Conclusions: In this work, we present a set of 397 enzyme models of T. cruzi that can constitute potential
structure-based drug targets to be investigated for the development of new strategies to fight Chagas’ disease.
The strategies presented here support the concept of structural analysis in conjunction with protein functional
analysis as an interesting computational methodology to detect potential targets for structure-based rational drug
design. For example, 2,4-dienoyl-CoA reductase (EC 1.3.1.34) and triacylglycerol lipase (EC 3.1.1.3), classified as
analogous proteins in relation to H. sapiens enzymes, were identified as new potential molecular targets.
Share